Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trial
乐伐替尼联合抗PD-1抗体作为不可切除的中晚期肝细胞癌患者的转化治疗：一项单臂II期试验
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2023-007366
Zhang, Wenwen; Tong, Shuang; Hu, Bingyang; Wan, Tao; Tang, Haowen; Zhao, Feilong; Jiao, Tianyu; Li, Junfeng; Zhang, Ze; Cai, Jinping; Ye, Huiyi; Wang, Zhanbo; Chen, Shiqing; Wang, Yafei; Li, Xuerui; Wang, Fangzhou; Cao, Junning; Tian, Lantian; Zhao, Xiaochen; Chen, Mingyi; Wang, Hongguang; Cai, Shouwang; Hu, Minggen; Bai, Yuezong; Lu, Shichun
